• Earlier this year, United States Antimony Corporation reported a company-wide update on its mining activities in Alaska, Montana, and Canada, confirming progress on multiple claims such as Ester Dome, Stibnite Creek, and Nolan Creek and outlining plans to begin mining operations later in 2026.
• The company also indicated that 2026 will be the first year it uses antimony ore from its own mines to fulfill customer contracts, a shift that could reshape its cost structure and supply reliability compared with relying solely on third-party ore.
• We’ll now examine how supplying customer contracts with its own mined ore may influence United States Antimony’s broader investment narrative and outlook.

Capitalize on the AI infrastructure supercycle with our selection of the 56 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

United States Antimony Investment Narrative Recap

To own United States Antimony today, you need to believe its push toward vertical integration and North American self supply can eventually translate into more stable margins despite current losses. The recent update on Alaska, Montana and Canada projects is important because the main near term catalyst is proving these assets can actually deliver ore on time, while the biggest risk remains permitting and logistical setbacks that could push out the 2026 self supply target.

The joint venture announced in February 2026 with Americas Gold and Silver to build an antimony processing plant in Idaho ties directly into this mining update. If USAC can align its new mine output with added processing capacity at the Galena Complex, it could better support long term contracts such as the US$106.7 million antimony trioxide supply agreement, but any delays on either side would weaken that production and contract fulfillment story.

However, investors should also be aware that if permitting obstacles in Alaska and Canada intensify...

United States Antimony's narrative projects $343.6 million revenue and $83.0 million earnings by 2029.

Uncover how United States Antimony's forecasts yield a $13.06 fair value, a 113% upside to its current price.

Exploring Other Perspectives

The most optimistic analysts were already modeling revenue of about US$333 million and earnings near US$72 million by 2029, so when you compare that bullish view with the new mine supply update and the heavy dependence on long term government and industrial contracts, it underlines just how differently people can frame the same story and why it is worth exploring several perspectives before you decide what feels realistic.

Explore 15 other fair value estimates on United States Antimony - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your United States Antimony research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free United States Antimony research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate United States Antimony's overall financial health at a glance.

Looking For Alternative Opportunities?

Our top stock finds are flying under the radar-for now. Get in early:

• Find 52 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.